Ask Warren

BioSmart

038460 · KOSDAQ · ₩038460 · 바이오스마트

₩2,495▲ ₩35 (1.42%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩168B₩145B₩124B₩126B₩121B₩112B₩116B₩119B
Cost of sales₩148B₩121B₩103B₩103B₩101B₩91B₩95B₩98B
Gross profit₩19B₩24B₩21B₩22B₩20B₩22B₩21B₩21B
Operating income₩5.1B₩10B₩5.1B₩7.6B₩4.2B₩5.6B₩7.2B₩3.8B
Net income−₩5B₩7.2B₩4.1B₩7.7B−₩5.6B₩2.8B₩2.6B₩3.2B
Net income to shareholders₩1.1B₩4.7B₩3.8B₩4B−₩988M₩2.2B₩2B−₩1.5B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩345B₩318B₩310B₩288B₩286B₩267B₩263B₩267B
Current assets₩181B₩161B₩154B₩161B₩159B₩139B₩134B₩140B
Cash and equivalents₩38B₩16B₩30B₩33B₩32B₩15B₩11B₩14B
Total liabilities₩148B₩124B₩122B₩109B₩112B₩108B₩106B₩122B
Current liabilities₩126B₩92B₩90B₩86B₩83B₩80B₩79B₩95B
Borrowings₩80B₩74B₩72B₩56B₩54B₩53B₩48B₩62B
Total equity₩197B₩195B₩188B₩179B₩174B₩159B₩156B₩144B
Shareholders' equity₩150B₩149B₩144B₩140B₩136B₩132B₩129B₩118B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩12B−₩9.8B₩10B₩7.6B₩6.6B−₩451M₩10B₩11B
Capital spending₩6.7B₩4.8B₩30B₩1B₩1.6B₩977M₩1.6B₩2.6B
Free cash flow₩5.2B−₩15B−₩19B₩6.6B₩5B−₩1.4B₩8.6B₩8.1B

Consolidated where available. Amounts in won.

Also known as: BioSmart / 바이오스마트 / 038460 / KRX:038460

Source: KRX statistical information